Navigation Links
Frost & Sullivan Recognizes Excellence in Medical Technologies & Life Sciences
Date:3/24/2009

alysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

For further information on the Awards Banquet or recipients, or for digital photos, please contact Jake Wengroff, jake.wengroff@frost.com.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 31 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.

    Contact:
    Jake Wengroff
    210.247.3806
    jake.wengroff@frost.com


'/>"/>
SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Transport Pharmaceuticals Receives Coveted Frost & Sullivan Technology Innovation Award
2. Nonin Medical, Inc. Receives Frost & Sullivans 2007 Award for Product Differentiation Innovation
3. Digirad Corporation to Receive Frost & Sullivan 2007 North American Award for Product Strategy
4. Signalife Wins Second Frost & Sullivan Technology Award
5. AdvanDx Receives Frost & Sullivans Rapid In-Vitro Diagnostic Technology Innovation of the Year Award
6. Modigene Announces Closing of $12 Million Financing by Members of The Frost Group
7. WuXi PharmaTech (NYSE: WX) Wins the 2008 Frost & Sullivan Award for Best in Class Outsourced R&D in Pharmaceuticals and Biotechnology
8. Exiqon Receives the 2008 Frost & Sullivan Growth Strategy Leadership Award
9. Athera Biotechnology Founder Johan Frostegard and His Colleagues Win NACB Distinguished Abstract Award at AACC 2008
10. Vascular Biogenics Ltd. Presented With the Frost & Sullivan 2008 European Gene Expression Targeting Platform Technology Innovation Award
11. Frost & Sullivan Recognizes Kionixs Dominance in the MEMS Accelerometers Market Through Product Line Strategy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... North Shore Towers, a luxury co-op community based ... one of the nation’s leading combined heating and power (CHP) ... 43-year-old CHP system. The original CHP system had been maintained ... the life of the plant, GI Energy was contracted to ... recovery equipment, while maintaining continuous operation of the entire complex. ...
(Date:7/31/2014)... -- Research and Markets has announced the ... report to their offering. ... the genetic material or genomes of an organism. It ... discovery and development of diagnostic and therapeutic solutions for ... is supported by three major product segments: Instruments, Consumables, ...
(Date:7/31/2014)... July 31, 2014 Senomyx , ... company using proprietary taste science technologies to discover, ... food, beverage, and ingredient supply industries, today reported ... Company ended the second quarter with $33.6 million ... "During the past quarter Senomyx achieved another ...
(Date:7/31/2014)... SHENZHEN, China , July 31, 2014 ... an Irys™System by BGI , the ... enable comprehensive exploration of human structural variation (SV) and ... interest, including those where no reference exists. In addition, ... methods for multiplexing on the Irys System, enabling significantly ...
Breaking Biology Technology:North Shore Towers Partners with GI Energy to Install Turnkey Natural Gas-Fired Combined Heat and Power Plant 2Global Genomics Market 2014-2018: Key Vendors are F. Hoffmann-La Roche, Life Technologies, Qiagen and Illumina 2SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 14SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 15SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 16BioNano Genomics Announces the Purchase of the Irys System by BGI 2BioNano Genomics Announces the Purchase of the Irys System by BGI 3BioNano Genomics Announces the Purchase of the Irys System by BGI 4
... 2011 Sigma Life Science, the innovative biological ...  SIAL), and King,s College London, today announced an ... for the identification and validation of microRNA (miRNA) ... detailed information, visit www.wherebiobegins.com/targetid . ...
... Reportlinker.com announces that a new market research report is available ... http://www.reportlinker.com/p0489604/Genetics-Reports-Bundle.html Report Description ... TriMark Publications reports at a15% discount off the individual reports being ... DNA Sequencing and PCR Markets. - Gene Expression ...
... Highlights First Quarter 2011: First ... to Alexandria Real Estate Equities, Inc.,s Common Stockholders of $1.15, ... Up 6% Compared to First Quarter 2010 FFO Per Share ... (Diluted) Attributable to Alexandria Real Estate Equities, Inc.,s Common Stockholders ...
Cached Biology Technology:Sigma® Life Science and King's College London Co-Developing miRNA Target Identification Technology 2Sigma® Life Science and King's College London Co-Developing miRNA Target Identification Technology 3Sigma® Life Science and King's College London Co-Developing miRNA Target Identification Technology 4Reportlinker Adds Genetics Reports Bundle 2Reportlinker Adds Genetics Reports Bundle 3Reportlinker Adds Genetics Reports Bundle 4Reportlinker Adds Genetics Reports Bundle 5Reportlinker Adds Genetics Reports Bundle 6Reportlinker Adds Genetics Reports Bundle 7Reportlinker Adds Genetics Reports Bundle 8Reportlinker Adds Genetics Reports Bundle 9Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 2Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 3Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 4Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 5Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 6Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 7Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 8Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 9Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 10Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 11Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 12Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 13Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 14Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 15Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 16
(Date:8/1/2014)... the UC Davis Center for Neuroscience and Department ... and Engineering Faculty Fellowship from the U.S. Department ... support new work on learning and memory in ... The new project aims to connect neural oscillations, ... the cortex and hippocampus, brain regions that are ...
(Date:8/1/2014)... marine mammals have officially named a species new ... sahulensis , according to the Wildlife Conservation Society ... the newly named species is the culmination of ... historical records, physical descriptions, and genetic data of ... from the coast of West Africa to the ...
(Date:8/1/2014)... in stem cell research will provide enormous opportunities ... stem cells could replicate any other cells in ... disease, repairing damaged spinal cords, treating kidney, liver ... The potential for profit is staggering. Prof. Jinhui ... this field of research still faces myriad biological, ...
Breaking Biology News(10 mins):Scientists name new species of cetacean: The Australian humpback dolphin 2Scientists name new species of cetacean: The Australian humpback dolphin 3
... (PHILADELPHIA) Scientists at Jefferson Medical College have received ... funded by the National Heart, Lung and Blood Institute ... of platelet gene expression. The study aims to find ... strategies and develop better predictors of cardiovascular disease. ...
... Researchers have tracked a cell-to-cell signaling pathway that designates ... embryonic mice. The scientists succeeded in activating this signal ... inner ear. Patches of sensory structures began growing in ... structures contained tufted cells, called hair cells, which respond ...
... New ground broken by Michigan State University biochemists ... temperatures and could lead to discoveries related to ... "This brings together two classic problems in ... biochemistry and molecular biology. "One is that plants ...
Cached Biology News:Jefferson receives $3 million NIH grant to study molecular and genetic mechanisms in platelets 2Tuning into cell signals that tell where sensory organs will form inside the ear 2Tuning into cell signals that tell where sensory organs will form inside the ear 3Researchers discover novel mechanism protecting plants against freezing 2
Human FGF R2 (alpha isoforms) MAb (Clone 98706)...
dithiothreitol, sulfhydryl reducing agent, C4H10O2S2; MW: 154.24, 97% pure (minimum), CAS No: 27565-41-9, store at -20 C ...
... the simple, phenol-free extraction of genomic DNA ... proteinase K digestion.Each kit is designed to ... of up to 25 mg of hard ... and Amplification of Genomic DNA, Nucleon DNA ...
Human LT beta R/TNFRSF3 Phycoerythrin MAb (Clone 71319)...
Biology Products: